Quantcast Cold Antibodies - Immunohematology and Blood Banking II

Share on Google+Share on FacebookShare on LinkedInShare on TwitterShare on DiggShare on Stumble Upon
Custom Search
 
  
 
(2)  Variation in the strength of the antigen. Some antigens that do not show
dosage in terms of zygosity may vary in strength on cells from different individuals. The
antigens most notable for this are P1, Sda, Lea, Leb, and I. Sometimes diminished
antigenic strength can be related to disease, or to the length of time that the cell
suspension has been stored.
1-38. COLD ANTIBODIES
a. Background. These antibodies react best at room temperature (RT) and
below, while reactions after 37C incubation and with AGT are negative or weakly
positive. Some cold agglutinating antibodies, notably anti-I, anti-lH, and anti-H, bind
complement following the antigen-antibody interaction at low temperatures; subsequent
37C incubation may cause the antibody to elute from the cell, but the attached
complement remains, and produces a positive reaction when antiglobulin serum is
added. An antibody displaying these characteristics in the screening test or in
crossmatches should be tested at 18C and/or 4C with specially selected cells, such as
cord cells.
b. Cold Autoabsorption to Remove Cold-Reactive Autoantibody.
(1)  When a strong, cold, autoantibody is present, meaningful
antibody-screening and compatibility studies cannot be done until the autoantibody is
removed. This can be done with the patient's untreated or enzyme-treated cells.
Enzyme pretreatment results in faster antibody removal, and is more effective with very
high-titered autoantibodies. Untreated autoabsorption is usually satisfactory for
removing low-level activity.
(2)  Some alloantibody may also be removed by the Matuhasi-Ogata
phenomenon, or by transfused cells in the circulation. In recently transfused patients,
when autoabsorption might result in removing alloantibody activity, the
antibody-screening test and compatibility tests should be done at 37C, using serum
from a blood sample clotted at 37C and kept at that temperature until the serum is
removed. This permits detection of antibodies active at 37C, and by AGT, but not
cold-reactive alloantibodies.
(a) STEP 1. Obtain a blood specimen from the patient. At the bedside
draw two specimens of blood, one in a tube immediately placed in ice, the other in a
tube containing anticoagulant and incubate it at once at 37C. To do this, bring a
heated block, water bath, or vacuum jug of 37C water to the patient's bedside. The
tube may also be transported in an inside pocket.
(b) STEP 2. Allow the first (iced) specimen to clot in the refrigerator.
Separate the serum by centrifuging in ice-filled cups or a refrigerated centrifuge.
Immediately remove the serum from the clot.
MD0846
1-52



Medical News
Team finds new genetic anomalies in lung cancer
Developing effective treatments for lung cancer has been challenging, in...
medicalxpress.com
Abandoned asbestos mines still a hazard in India
Asbestos waste spills in a gray gash down the flank...
medicalxpress.com
Radiologist recommendations for chest CT have high clinical yield
A substantial percentage of patients who receive radiologist recommendations for...
medicalxpress.com
IMF lending undermined healthcare provision in Ebola-stricken West Africa
Writing today in the journal Lancet Global Health, researchers from...
medicalxpress.com
Seeing the doctor, overseas: Medical tourism booms in Asia
The lines snaking into Bangladesh's overwhelmed hospitals are often so...
medicalxpress.com
Bone loss drugs may help prevent endometrial cancer
A new analysis suggests that women who use bisphosphonates—medications commonly...
medicalxpress.com
Consumer purchases of cakes, cookies, pies have decreased by 24 percent
Ready-to-eat grain-based desserts (RTE GBDs) are pre-packaged consumer baked goods...
medicalxpress.com
Tips offered to docs, spouses for maintaining happy marriage
(HealthDay)—Simple tips can help physicians and their spouses maintain marital...
medicalxpress.com
Risks ID'd for referral-warranted retinopathy of prematurity
(HealthDay)—Predictors have been identified for referral-warranted (RW)-retinopathy of prematurity (ROP),...
medicalxpress.com
SLNB doesn't up survival in melanoma arising in head, neck
(HealthDay)—For patients with melanoma arising in head and neck subsites...
medicalxpress.com
The Week Ahead: Diabetes Drugs, Musical Medicos
(MedPage Today) -- What do we really know about drug...
medpagetoday.com
Evidence plays limited role in OTC decision making
(HealthDay)—For pharmacy graduates and tutors, evidence seems to play a...
medicalxpress.com
Shared medical appointments beneficial in geriatric care
(HealthDay)—For older patients, a shared medical appointment (SMA) program facilitates...
medicalxpress.com
Synovitis Is Precursor of Radiographic Knee OA
(MedPage Today) -- Study finds inflammation plays early role in...
medpagetoday.com
Side Effects Strike Third of Arthritic Kids on Biologics
(MedPage Today) -- Anti-TNF agents a concern in juvenile idiopathic...
medpagetoday.com
Restrictions lifted at British bird flu farm
Britain on Sunday lifted all restrictions at a duck farm...
medicalxpress.com
Sierra Leone urges safe burials to stem Ebola
The radio announcement is chilling and blunt: "If I die,...
medicalxpress.com
Training Location Key to Medicare Billing Practices (CME/CE)
(MedPage Today) -- As the resident is trained, so the...
medpagetoday.com
First successful vaccination against 'mad cow'-like wasting disease in deer
Researchers at NYU Langone Medical Center and elsewhere say that...
medicalxpress.com
The Slippery Slope: A Bittersweet Diabetes Economy
(MedPage Today) -- From 2004 to 2013, none of the...
medpagetoday.com
 


Privacy Statement - Copyright Information. - Contact Us

comments powered by Disqus

Integrated Publishing, Inc.
9438 US Hwy 19N #311 Port Richey, FL 34668

Phone For Parts Inquiries: (727) 755-3260
Google +